Intezyne Technologies logo — company profile

Intezyne Technologies

Founded 2004 United States Tampa, United States 4 employees Series A Total: $10.48M Biotechnology, Health Care

General Information

Company Name Intezyne Technologies
Founded Year 2004
Location United States Tampa, United States +1
Founders / Decision Makers
Team member
Employees 4
Industries Biotechnology, Health Care
Funding Stage Series A
Social

Get notified when Intezyne Technologies moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Intezyne Technologies

Intezyne Technologies is a clinical-stage biotechnology company founded in 2004 with headquarters in the United States. The company is dedicated to enhancing the efficacy of cancer treatments by leveraging a range of proprietary assets. Its portfolio is being advanced through various stages of the clinical approval process.

The most recent funding event for Intezyne Technologies was a $10.00M Series A investment, which took place on 06 October 2017. The investment was led by Gaston Capital Partners.

Intezyne Technologies' focused approach to improving cancer treatment effectiveness and its progress in advancing through clinical stages make it an intriguing prospect, showcasing potential for significant impact in the biotechnology and healthcare industries.

Taxonomy: Cancer Treatment, Drug Delivery, Nanoparticles, Clinical-stage, Synthetic Polymers, IVECT Method, Chemotherapy, Biomedical Research, Clinical Approval, Small Molecules, Nucleic Acids, Oligopeptides, Diagnostic Imaging Agents, Clinical Trials

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Series A •••••• 1
Investor
06 Oct 2017
Venture Round •••••• - 01 Jun 2016

Intezyne Technologies Alternatives & Competitors

Intezyne Technologies vs

Developing tomorrow's cancer therapies. Today.

Corporate Round
24 employees
Biotechnology, Health Care
Intezyne Technologies vs
TRIMEDX
TRIMEDX United States

Unlock the full potential of your clinical assets

Debt Financing
2657 employees
Health Care
Intezyne Technologies vs

Pioneering pharmaceutical innovation through a strategic semi-virtual model to deliver targeted, cos...

Debt Financing
3 employees
Biotechnology, Health Care

FAQ About Intezyne Technologies

Intezyne is a clinical-stage biotechnology company focused on increasing the effectiveness of cancer treatments through the application of a diverse portfolio of proprietary assets. The Company is currently advancing these assets through various stages of the clinical approval process.
Intezyne Technologies was founded in 2004.
Intezyne Technologies is headquartered in Tampa, United States.
Intezyne Technologies operates in the following industries: Biotechnology, Health Care.
Intezyne Technologies has approximately 4 employees.
Intezyne Technologies has completed 2 funding rounds, raising a total of $10.48M. The latest funding stage is Series A.
Top alternatives and competitors to Intezyne Technologies include invIOs INNOVATIVE IMMUNO-ONCOLOGY, TRIMEDX, Achelios Therapeutics, Leaf Vertical, Formation Bio. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Intezyne Technologies and invIOs INNOVATIVE IMMUNO-ONCOLOGY are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Intezyne Technologies and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

One analytics cookie (Google Analytics). Cookie Policy

Book a demo 30 minutes